Ttbio Corp.

Taipei Exchange 6493.TWO

Ttbio Corp. Price to Sales Ratio (P/S) on January 13, 2025: 1.34

Ttbio Corp. Price to Sales Ratio (P/S) is 1.34 on January 13, 2025, a -9.16% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Ttbio Corp. 52-week high Price to Sales Ratio (P/S) is 1.60 on September 24, 2024, which is 19.20% above the current Price to Sales Ratio (P/S).
  • Ttbio Corp. 52-week low Price to Sales Ratio (P/S) is 1.34 on January 13, 2025, which is 0.00% below the current Price to Sales Ratio (P/S).
  • Ttbio Corp. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.48.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Taipei Exchange: 6493.TWO

Ttbio Corp.

CEO Shu Rong Yang
IPO Date Jan. 8, 2015
Location
Headquarters No. 07, 6th Road Industry Park
Employees 101
Sector Health Care
Industries
Medical Instruments Pharmaceuticals
Description

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email